Tyche Industries Ltd
₹ 110
-2.22%
11 Sep
3:40 p.m.
About
Incorporated in 1998, Tyche Industries Ltd
does manufacturing of active pharmaceutical ingredients[1]
Key Points
- Market Cap ₹ 113 Cr.
- Current Price ₹ 110
- High / Low ₹ 148 / 99.0
- Stock P/E 25.3
- Book Value ₹ 137
- Dividend Yield 3.20 %
- ROCE 6.83 %
- ROE 5.01 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Stock is trading at 0.81 times its book value
- Stock is providing a good dividend yield of 3.16%.
- Company has been maintaining a healthy dividend payout of 32.5%
Cons
- The company has delivered a poor sales growth of -7.28% over past five years.
- Company has a low return on equity of 8.05% over last 3 years.
- Earnings include an other income of Rs.9.72 Cr.
- Debtor days have increased from 110 to 133 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 63.86 | 54.08 | 42.61 | 51.60 | 53.95 | 73.70 | 78.24 | 62.27 | 75.39 | 69.51 | 65.47 | 53.63 | 50.04 | |
| 56.80 | 51.16 | 36.62 | 42.57 | 44.78 | 52.31 | 53.52 | 51.30 | 59.24 | 56.86 | 54.18 | 51.39 | 51.44 | |
| Operating Profit | 7.06 | 2.92 | 5.99 | 9.03 | 9.17 | 21.39 | 24.72 | 10.97 | 16.15 | 12.65 | 11.29 | 2.24 | -1.40 |
| OPM % | 11.06% | 5.40% | 14.06% | 17.50% | 17.00% | 29.02% | 31.60% | 17.62% | 21.42% | 18.20% | 17.24% | 4.18% | -2.80% |
| 0.25 | 1.68 | 1.89 | 1.69 | 2.52 | 3.68 | 3.75 | 3.46 | 4.71 | 5.92 | 7.42 | 9.22 | 9.72 | |
| Interest | 1.11 | 0.29 | 0.08 | 0.01 | -0.00 | -0.00 | 0.01 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | 0.00 |
| Depreciation | 3.34 | 1.76 | 1.87 | 1.85 | 1.84 | 1.74 | 1.72 | 1.79 | 1.77 | 1.94 | 1.99 | 2.00 | 2.16 |
| Profit before tax | 2.86 | 2.55 | 5.93 | 8.86 | 9.85 | 23.33 | 26.74 | 12.64 | 19.09 | 16.63 | 16.72 | 9.46 | 6.16 |
| Tax % | 32.87% | 3.53% | 48.06% | 33.86% | 27.41% | 24.73% | 25.24% | 26.11% | 25.72% | 26.40% | 25.72% | 26.74% | |
| 1.93 | 2.47 | 3.08 | 5.86 | 7.15 | 17.56 | 19.98 | 9.33 | 14.17 | 12.24 | 12.41 | 6.94 | 4.45 | |
| EPS in Rs | 1.88 | 2.41 | 3.00 | 5.72 | 6.98 | 17.13 | 19.49 | 9.10 | 13.82 | 11.94 | 12.11 | 6.77 | 4.34 |
| Dividend Payout % | 26.50% | 20.71% | 16.61% | 8.75% | 7.17% | -0.00% | 5.13% | 16.48% | -0.00% | 20.94% | 24.78% | 51.69% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | -7% |
| 3 Years: | -11% |
| TTM: | -21% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | -20% |
| 3 Years: | -21% |
| TTM: | -65% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | -10% |
| 3 Years: | -13% |
| 1 Year: | -18% |
| Return on Equity | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 9% |
| 3 Years: | 8% |
| Last Year: | 5% |
Balance Sheet
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10.23 | 10.23 | 10.23 | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 |
| Reserves | 33.56 | 35.36 | 37.66 | 42.88 | 50.02 | 66.93 | 85.72 | 93.97 | 106.51 | 116.49 | 126.46 | 130.23 |
| 8.68 | 10.83 | -0.00 | 0.07 | 0.04 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | |
| 11.51 | 11.01 | 13.10 | 13.52 | 13.70 | 17.52 | 20.98 | 16.05 | 19.95 | 7.95 | 10.69 | 7.56 | |
| Total Liabilities | 63.98 | 67.43 | 60.99 | 66.72 | 74.01 | 94.70 | 116.95 | 120.27 | 136.71 | 134.69 | 147.40 | 148.04 |
| 28.98 | 28.40 | 26.57 | 19.84 | 19.15 | 17.67 | 17.93 | 16.63 | 16.61 | 17.90 | 16.48 | 18.88 | |
| CWIP | 0.38 | 0.33 | 0.33 | -0.00 | -0.00 | -0.00 | 0.53 | -0.00 | -0.00 | -0.00 | 0.16 | -0.00 |
| Investments | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| 34.62 | 38.70 | 34.09 | 46.88 | 54.86 | 77.03 | 98.49 | 103.64 | 120.10 | 116.79 | 130.76 | 129.16 | |
| Total Assets | 63.98 | 67.43 | 60.99 | 66.72 | 74.01 | 94.70 | 116.95 | 120.27 | 136.71 | 134.69 | 147.40 | 148.04 |
Cash Flows
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.31 | 11.96 | 11.37 | 5.04 | 3.75 | 15.21 | 15.45 | 4.46 | 6.43 | 7.71 | 8.54 | 2.85 | |
| -0.98 | -1.34 | 0.60 | 6.29 | 0.63 | 2.04 | 0.42 | 3.16 | -3.12 | 3.94 | -0.39 | -8.95 | |
| -3.24 | 1.59 | -10.59 | -0.60 | -0.07 | -0.62 | -1.02 | -1.02 | -1.54 | -2.05 | -2.56 | -3.07 | |
| Net Cash Flow | -1.90 | 12.20 | 1.38 | 10.72 | 4.31 | 16.63 | 14.85 | 6.59 | 1.77 | 9.61 | 5.59 | -9.17 |
| Free Cash Flow | 1.33 | 10.82 | 11.33 | 10.25 | 2.61 | 14.95 | 12.95 | 4.58 | 4.68 | 4.48 | 7.84 | -1.39 |
| CFO/OP | 33% | 410% | 190% | 56% | 41% | 71% | 62% | 41% | 40% | 61% | 76% | 127% |
Ratios
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 90.65 | 106.71 | 81.12 | 68.05 | 68.81 | 64.04 | 79.91 | 96.25 | 106.90 | 100.40 | 95.45 | 132.99 |
| Inventory Days | 138.26 | 67.76 | 83.68 | 85.37 | 122.85 | 121.71 | 148.08 | 148.32 | 195.21 | 157.11 | 244.61 | 149.93 |
| Days Payable | 75.69 | 92.82 | 130.50 | 86.81 | 95.79 | 91.41 | 93.04 | 77.86 | 134.49 | 47.91 | 85.26 | 37.78 |
| Cash Conversion Cycle | 153.22 | 81.65 | 34.30 | 66.61 | 95.87 | 94.34 | 134.95 | 166.71 | 167.62 | 209.60 | 254.79 | 245.13 |
| Working Capital Days | 77.39 | 21.46 | 60.48 | 66.63 | 86.53 | 77.11 | 82.76 | 121.22 | 128.74 | 144.30 | 149.58 | 177.43 |
| ROCE % | 7.37% | 5.22% | 11.52% | 17.55% | 17.36% | 33.92% | 32.04% | 13.32% | 17.39% | 13.66% | 12.68% | 6.83% |
Insights
In beta| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Electricity Consumption Lakh KWH |
|
||||||||
| Export Revenue Share % |
|||||||||
| Husk Consumption MT |
|||||||||
| R&D Expenditure Rs Lakhs |
|||||||||
| Number of Permanent Employees count |
|||||||||
| R&D Personnel Count count |
|||||||||
| R&D Expenditure (Percentage of Turnover) % |
|||||||||
Requires Premium
Requires Premium
Extracted by Screener AI
Documents
Announcements
-
Corrigendum To The Annual Report For The Financial Year 2025-26
- Tyche Industries issued a corrigendum to FY2025-26 annual report, correcting ratio analysis notes and percentages.
-
Intimation Under Regulations 30 And 36(1)(B) Of The SEBI Listing Regulations.
- Tyche Industries scheduled 28th AGM on September 30, 2026 and shared annual report web-links.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
- Newspaper Publication, 28th Annual General Meeting
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
- Newspaper Publication, 28th Annual General Meeting
- Reg. 34 (1) Annual Report.
Annual reports
-
Annual Report 2026
from bse
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
-
Annual Report 2021
from bse
-
Annual Report 2020
from bse
-
Annual Report 2019
from bse
-
Annual Report 2018
from bse
-
Annual Report 2017
from bse
-
Annual Report 2016
from bse
-
Annual Report 2015
from bse
-
Annual Report 2014
from bse
-
Annual Report 2013
from bse
-
Annual Report 2012
from bse
Business Overview:[1]
TIL is a manufacturer and exporter of Active Pharmaceutical Ingredients, Intermediates and Nutraceuticals. It is one of the largest manufacturers in India of Glucosamine Hydrochloride and the corresponding sodium and potassium salts, which are mainly exported to the USA and Europe.